DuPont de Nemours, Inc. $DD Shares Sold by Greenleaf Trust

Key Points

• Greenleaf Trust reduced its stake in DuPont de Nemours by 25.7%, owning 13,823 shares worth $948,000 after selling 4,779 shares in Q2.
• Insider selling included SVP Steven P. Larrabee selling 43,208 shares for over $3.33 million, which represents a 52.83% decrease in his ownership.
• Analysts have mixed views on DuPont's stock, with a consensus of "Moderate Buy" and an average target price of $88.33, despite BMO Capital Markets reducing its target from $107.00 to $104.00.

Greenleaf Trust trimmed its position in DuPont de Nemours, Inc. (NYSE:DD - Free Report) by 25.7% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 13,823 shares of the basic materials company's stock after selling 4,779 shares during the period. Greenleaf Trust's holdings in DuPont de Nemours were worth $948,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of DD. JNBA Financial Advisors grew its stake in DuPont de Nemours by 132.5% in the first quarter. JNBA Financial Advisors now owns 379 shares of the basic materials company's stock worth $28,000 after purchasing an additional 216 shares in the last quarter. Valley National Advisers Inc. grew its stake in DuPont de Nemours by 145.0% in the first quarter. Valley National Advisers Inc. now owns 419 shares of the basic materials company's stock worth $31,000 after purchasing an additional 248 shares in the last quarter. WPG Advisers LLC acquired a new position in DuPont de Nemours in the first quarter worth about $35,000. Ransom Advisory Ltd acquired a new position in DuPont de Nemours in the first quarter worth about $40,000. Finally, Thurston Springer Miller Herd & Titak Inc. lifted its holdings in DuPont de Nemours by 1,770.0% in the first quarter. Thurston Springer Miller Herd & Titak Inc. now owns 561 shares of the basic materials company's stock worth $42,000 after acquiring an additional 531 shares during the last quarter. 73.96% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, SVP Steven P. Larrabee sold 43,208 shares of the business's stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $77.17, for a total transaction of $3,334,361.36. Following the sale, the senior vice president owned 38,585 shares of the company's stock, valued at $2,977,604.45. The trade was a 52.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold a total of 74,208 shares of company stock worth $5,714,861 over the last quarter. 0.61% of the stock is owned by insiders.

Wall Street Analyst Weigh In

DD has been the topic of a number of recent research reports. BMO Capital Markets cut their target price on shares of DuPont de Nemours from $107.00 to $104.00 and set an "outperform" rating on the stock in a report on Friday, September 19th. Mizuho raised their target price on shares of DuPont de Nemours from $80.00 to $85.00 and gave the stock an "outperform" rating in a report on Tuesday, July 15th. KeyCorp raised their target price on shares of DuPont de Nemours from $92.00 to $93.00 and gave the stock an "overweight" rating in a report on Monday, September 22nd. Royal Bank Of Canada reissued an "outperform" rating and issued a $94.00 target price on shares of DuPont de Nemours in a report on Friday, September 19th. Finally, Wells Fargo & Company raised their target price on shares of DuPont de Nemours from $81.00 to $90.00 and gave the stock an "overweight" rating in a report on Monday, July 14th. Nine analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $88.33.

DuPont de Nemours Price Performance

Shares of NYSE:DD opened at $78.23 on Thursday. DuPont de Nemours, Inc. has a 12 month low of $53.77 and a 12 month high of $88.62. The stock has a market cap of $32.76 billion, a price-to-earnings ratio of -166.45, a PEG ratio of 2.25 and a beta of 1.09. The stock's 50 day moving average price is $75.29 and its 200 day moving average price is $70.97. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.41 and a quick ratio of 0.94.

DuPont de Nemours (NYSE:DD - Get Free Report) last announced its earnings results on Tuesday, August 5th. The basic materials company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.06 by $0.06. DuPont de Nemours had a positive return on equity of 7.85% and a negative net margin of 1.54%.The firm had revenue of $3.26 billion for the quarter, compared to analysts' expectations of $3.23 billion. During the same quarter in the previous year, the company earned $0.97 earnings per share. The firm's quarterly revenue was up 2.7% compared to the same quarter last year. DuPont de Nemours has set its FY 2025 guidance at 4.400-4.400 EPS. Q3 2025 guidance at 1.150-1.150 EPS. Equities research analysts anticipate that DuPont de Nemours, Inc. will post 4.38 earnings per share for the current fiscal year.

DuPont de Nemours Company Profile

DuPont de Nemours, Inc provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through Electronics & Industrial, Water & Protection, and Corporate & Other segments. The Electronics & Industrial segment supplies materials and solutions for the fabrication of semiconductors and integrated circuits.

Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.